Interleukin-12-anchored exosomes increase cytotoxicity of T lymphocytes by reversing the JAK/STAT pathway impaired by tumor-derived exosomes

International Journal of Molecular Medicine

Volumn 25, Issue 5, 2010, Pages 695-700

  Zhang, Yao ^a   Wu, Xiao Hou ^a   Luo, Chun Li ^a   Zhang, Jia Mo ^a   He, Bai Cheng ^a   Chen, Gang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Exosomes; Interleukin 12; Signal transduction; Tumor immunology

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 12P40; JANUS KINASE 2; JANUS KINASE 3; STAT5 PROTEIN;

ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; EXOSOME; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

EID: 77951699755     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000393     Document Type: Article

References (30)

1. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ and Geuze HJ: B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183: 1161-1172, 1996.
2. Andre F, Schartz NE, Movassagh M, et al: Malignant effusions and immunogenic tumor-derived exosomes. Lancet 360: 295-305, 2002. (Pubitemid 34874721)
3. Chaput N, Taïeb J, Schartz NE, André F, Angevin E and Zitvogel L: Exosome-based immunotherapy. Cancer Immunol Immunother 53: 234-239, 2004.
4. Wolfers J, Lozier A, Raposo G, et al: Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7: 297-303, 2001. (Pubitemid 32224344)
5. Théry C, Zitvogel L and Amigorena S: Exosomes: composition, biogenesis and function. Nat Rev Immunol 2: 569-579, 2002.
6. Dai S, Wan T, Wang B, et al: More efficient induction of HLAA0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells. Clin Cancer Res 11: 7554-7563, 2005. (Pubitemid 41507718)
7. Andreola G, Rivoltini L, Castelli C, et al: Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med 195: 1303-1316, 2002. (Pubitemid 34564332)
8. Huber V, Fais S, Iero M, et al: Human colorectal cancer cells induce T-cell death through release of proapoptotic micro-vesicles: role in immune escape. Gastroenterology 128: 1796 - 1804, 2005.
9. Kim JW, Wieckowski E, Taylor DD, Reichert TE, Watkins S, and Whiteside TL: Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin Cancer Res 11: 1010-1020, 2005. (Pubitemid 40175748)
10. Zhang HG, Kim H, Liu C, et al: Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. Biochim Biophys Acta 1773: 1116-1123, 2007. (Pubitemid 46898676)
11. Taylor DD and Gerçel TC: Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br J Cancer 92: 305-311, 2005.
12. Taylor DD, Gerçel TC, Lyons KS, Stanson J and Whiteside TL: T-cell apoptosis and suppression of T-cell receptor/CD3-ζ by Fas ligand-containing membranous vesicles shed from ovarian tumor. Clin Cancer Res 9: 5113-5119, 2003. (Pubitemid 37413559)
13. Trinchieri G: Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84: 4008-4027, 1994.
14. Colombo MP and Trinchieri G: Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev 13: 155-168, 2002.
15. Gollob JA, Murphy EA, Mahajan S, Schnipper CP, Ritz J and Frank D: Altered interleukin-12 responsiveness in Th1 and Th2 cells is associated with the differential activation of STAT5 and STAT1. Blood 91: 1341-1354, 1998. (Pubitemid 28086888)
16. Ahn HJ, Tomura M, Yu WG, Iwasaki M, Park WR, Hamaoka T, and Fujiwara H: Requirement for distinct janus kinases and STAT proteins in T cell proliferation versus IFN-γ production following IL-12 stimulation. J Immunol 161: 5893-5900, 1998. (Pubitemid 28535956)
17. Morales VA, Smits HH, Cantrell DA and Hilkens CM: Sustained IL-12 signaling is required for Th1 development. J Immunol 172: 61-69, 2004. (Pubitemid 38020456)
18. Sangro B, Melero I, Qian C and Prieto J: Gene therapy of cancer based on interleukin 12. Current Gene Therapy 5: 573-581, 2005. (Pubitemid 43009502)
19. Nagarajan S and Selvaraj P: Glycolipid-anchored IL-12 expressed on tumor cell surface induced antitumor immune response. Cancer Res 62: 2869-2874, 2002. (Pubitemid 34525773)
20. Nagarajan S and Selvaraj P: Human tumor membrane vesicles modified to express glycolipid-anchored IL-12 by protein transfer induce T cell proliferation in vitro: A potential approach for local delivery of cytokines during vaccination. Vaccine 24: 2264-2274, 2006. (Pubitemid 43290408)
21. Zhang Y, Luo C-L, He B-C, Zhang J-M and Cheng G, Wu X-H: Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma. Int J Oncol 36: 133-140, 2010.
22. Wang YC, Zhu L, McHugh R, et al: Induction of autologous tumor-specific cytotoxic T-lymphocyte activity against a human renal carcinoma cell line by B7-1 (CD80) costimulation. J Immunother 19: 1-8, 1996. (Pubitemid 26127362)
23. Liu DC, Yu J, Chen HY, Reichman R, Wu HL and Jin X: Statistical determination of threshold for cellular division in the CFSE-labeling assay. J Immunol Methods 312: 126-136, 2006. (Pubitemid 44209012)
24. Zitvogel L, Regnault A, Lozier A, et al: Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nature Med 4: 594-600, 1998. (Pubitemid 28237359)
25. Karagiannis SN, Bracher MG, Hunt J, et al: IgE-antibody-dependent immunotherapy of solid tumors: Cytotoxic and phagocytic mechanisms of eradication of ovarian cancer cells. J Immunol 179: 2832-2843, 2007.
26. Keller S, Sanderson MP, Stoeck A and Altevogt P: Exosomes: from biogenesis and secretion to biological function. Immunol Lett 107: 102-108, 2006. (Pubitemid 44779821)
27. Taylor DD and Black PH: Neoplastic and development importance of plasma membrane vesicles. Am Zool 26: 411-415, 1987.
28. Valenti R, Huber V, Filipazzi P, et al: Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res 66: 9290-9298, 2006. (Pubitemid 44521151)
29. Schindler C, Levy DE and Decker T: JAK-STAT signaling: from interferons to cytokines. J Biol Chem 282: 20059-20063, 2007.
30. Walker and Smith: The Jak-STAT pathway in rheumatoid arthritis. J Rheumatol 32: 1650-1653, 2005